PRIVATE POLICY | Survey May 2025

Data controller

Regen Lab SA, En Budron B2, 1052 Le Mont-sur-Lausanne, Switzerland, is responsible for processing the data collected in this questionnaire.

Purpose of processing

The data collected is intended to analyze current surgical practices in order to support the design of a future cartilage implant, in line with medical device development requirements.

Type of data collected

Only non-sensitive professional information is collected, such as :

– Medical specialty,

– Years of experience,

– Country of practice.

No health data or personally identifiable information (surname, first name, contact details) will be collected.

Legal basis for processing

Processing is based on Regen Lab SA’s legitimate interest in developing medical devices that meet the needs of professional users (Article 6, paragraph 1, point f of the RGPD).

Voluntary nature

Participation in this questionnaire is entirely voluntary. The participant may refuse or discontinue participation at any time without justification.

Confidentiality and anonymity

Responses will be analyzed in aggregate. No individual results will be published. Data will be stored securely and access will be restricted to Regen Lab SA’s clinical and development teams.

Data retention period

Data will be kept for a maximum of five (5) years from the end of the study, after which it will be deleted.

Recipients of data

Data will not be transmitted to any third party, apart from the technical service providers ensuring the secure hosting of the questionnaire, under RGPD-compliant subcontracting agreements.

Data transfer outside the EEA

When Google Forms is used, data is stored on servers located in the European Union, insofar as the European data residency option is activated. Otherwise, a transfer to the United States may be carried out in accordance with the standard contractual clauses approved by the European Commission.

Participants' rights

In accordance with the applicable regulations (RGPD and Swiss LPD), participants have the following rights in particular:

– Right of access to their data,

– Right of rectification,

– Right to erasure (“right to be forgotten”),

– Right to restrict processing,

– Right to object to processing.

To exercise these rights, or if you have any questions about the processing of your data, please contact : compliance@regenlab.com 

Copyright © 2025 All rights reserved.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.